US · 21 CFR
21 CFR 601.93
Postmarketing safety reporting.
21 CFR Part 601 › Subpart H—Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible
Section text
Biological products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting applicable to all approved biological products.
Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-16